BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37852102)

  • 1. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice.
    Wayal V; Hsieh CC
    Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
    Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
    Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
    Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosa Mosqueta Oil Prevents Oxidative Stress and Inflammation through the Upregulation of PPAR-α and NRF2 in C57BL/6J Mice Fed a High-Fat Diet.
    González-Mañán D; D'Espessailles A; Dossi CG; San Martín M; Mancilla RA; Tapia GS
    J Nutr; 2017 Apr; 147(4):579-588. PubMed ID: 28298541
    [No Abstract]   [Full Text] [Related]  

  • 5. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress.
    Wei K; Wei Y; Xu W; Lu F; Ma H
    Food Funct; 2022 May; 13(10):5782-5793. PubMed ID: 35537139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
    Chen HL; Tsai TC; Tsai YC; Liao JW; Yen CC; Chen CM
    Nutr Diabetes; 2016 Dec; 6(12):e237. PubMed ID: 27941940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
    Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA
    Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
    Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
    Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
    Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice.
    Shankar K; Metzger NP; Lawrence C; Gupta D; Osborne-Lawrence S; Varshney S; Singh O; Richard CP; Zaykov AN; Rolfts R; DuBois BN; Perez-Tilve D; Mani BK; Hammer STG; Zigman JM
    Mol Metab; 2024 Jun; 84():101950. PubMed ID: 38697291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baked corn (Zea mays L.) and bean (Phaseolus vulgaris L.) snack consumption lowered serum lipids and differentiated liver gene expression in C57BL/6 mice fed a high-fat diet by inhibiting PPARγ and SREBF2.
    Dominguez-Uscanga A; Loarca-Piña G; Gonzalez de Mejia E
    J Nutr Biochem; 2017 Dec; 50():1-15. PubMed ID: 28965030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice.
    Tao W; Sun W; Liu L; Wang G; Xiao Z; Pei X; Wang M
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31744059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats.
    Farage AE; Abdo W; Osman A; Abdel-Kareem MA; Hakami ZH; Alsulimani A; Bin-Ammar A; Alanazi AS; Alsuwayt B; Alanazi MM; Antar SA; Kamel EM; Mahmoud AM
    Life Sci; 2023 Jun; 322():121688. PubMed ID: 37030617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridostigmine attenuated high-fat-diet induced liver injury by the reduction of mitochondrial damage and oxidative stress via α7nAChR and M3AChR.
    Xue R; Wu Q; Guo L; Ye D; Cao Q; Zhang M; Xian Y; Chen M; Yan K; Zheng J
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23671. PubMed ID: 38454809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
    Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
    Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent.
    Tetri LH; Basaranoglu M; Brunt EM; Yerian LM; Neuschwander-Tetri BA
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G987-95. PubMed ID: 18772365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
    Shen S; Wang K; Zhi Y; Dong Y
    Pharm Biol; 2022 Dec; 60(1):1949-1959. PubMed ID: 36205541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
    Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
    Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria.
    García-Berumen CI; Ortiz-Avila O; Vargas-Vargas MA; Del Rosario-Tamayo BA; Guajardo-López C; Saavedra-Molina A; Rodríguez-Orozco AR; Cortés-Rojo C
    Lipids Health Dis; 2019 Mar; 18(1):78. PubMed ID: 30927921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.